These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32588755)

  • 1. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
    Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
    Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
    Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
    Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
    Fluur C; Bolse K; Strömberg A; Thylén I
    J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, predictors, and outcomes of advance directives in implantable cardioverter-defibrillator recipients.
    Merchant FM; Binney Z; Patel A; Li J; Peddareddy LP; El-Chami MF; Leon AR; Quest T
    Heart Rhythm; 2017 Jun; 14(6):830-836. PubMed ID: 28232262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease: a systematic review of qualitative evidence.
    Pike A; Dobbin-Williams K; Swab M
    JBI Evid Synth; 2020 Nov; 18(11):2231-2301. PubMed ID: 32813405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic review.
    Wong F; Sit J; Wong E
    JBI Libr Syst Rev; 2012; 10(43):2785-2881. PubMed ID: 27820203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Advance Directive Perspectives and Associations with Preferences for End-of-Life Life-Sustaining Treatments among Patients with Implantable Cardioverter-Defibrillators.
    Kim J; Park HW; An M; Shim JL
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.
    Nielsen KM; Zwisler AD; Taylor RS; Svendsen JH; Lindschou J; Anderson L; Jakobsen JC; Berg SK
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011828. PubMed ID: 30746679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?
    Kalver E; Branch-Elliman W; Stolzmann K; Wachterman M; Shin MH; Schweizer ML; Mull HJ
    J Palliat Med; 2023 Feb; 26(2):175-181. PubMed ID: 36067080
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
    Freemantle M; Murtagh F
    BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review.
    Stoevelaar R; Brinkman-Stoppelenburg A; Bhagwandien RE; van Bruchem-Visser RL; Theuns DA; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2018 Aug; 17(6):477-485. PubMed ID: 29772911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.